Global Monogenic Disease Testing Market Research Report 2025(Status and Outlook)
Report Overview
Monogenic disease testing refers to the process of identifying genetic variations that are caused by a mutation in a single gene. This type of testing is crucial in diagnosing and understanding various inherited disorders such as cystic fibrosis, sickle cell anemia, and Huntington's disease. By analyzing specific genes, healthcare providers can determine an individual's risk of developing a particular genetic condition, allowing for personalized treatment plans and genetic counseling. Monogenic disease testing plays a significant role in precision medicine, as it enables targeted therapies and interventions based on an individual's genetic makeup.
The market for monogenic disease testing is experiencing steady growth due to several key market drivers. One of the primary factors driving market expansion is the increasing prevalence of genetic disorders worldwide. As awareness and understanding of genetic diseases grow, there is a rising demand for accurate and reliable testing methods to diagnose these conditions. Additionally, advancements in technology, such as next-generation sequencing and gene editing techniques, have significantly improved the efficiency and accuracy of monogenic disease testing, further fueling market growth. Moreover, the growing emphasis on personalized medicine and the shift towards preventive healthcare are driving the adoption of genetic testing services, including monogenic disease testing.
In addition to technological advancements and increasing disease prevalence, the market for monogenic disease testing is also influenced by factors such as government initiatives, healthcare infrastructure development, and strategic collaborations between industry players. Government support in the form of funding for genetic research and initiatives to integrate genetic testing into healthcare systems is boosting market growth. Furthermore, the expansion of healthcare facilities and the integration of genetic testing services into routine healthcare practices are creating more opportunities for market players. Collaborations between diagnostic laboratories, research institutions, and pharmaceutical companies are also driving innovation and expanding the range of genetic tests available in the market.
This report provides a deep insight into the global Monogenic Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Monogenic Disease Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Monogenic Disease Testing market in any manner.
Global Monogenic Disease Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Celera Support Services
Abbott
ELITech Group
Auto Genomics
PerkinElmer
Bio-Rad Laboratories
Market Segmentation (by Type)
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive and Pre-Symptomatic Testing
Prenatal Testing
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monogenic Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Monogenic disease testing refers to the process of identifying genetic variations that are caused by a mutation in a single gene. This type of testing is crucial in diagnosing and understanding various inherited disorders such as cystic fibrosis, sickle cell anemia, and Huntington's disease. By analyzing specific genes, healthcare providers can determine an individual's risk of developing a particular genetic condition, allowing for personalized treatment plans and genetic counseling. Monogenic disease testing plays a significant role in precision medicine, as it enables targeted therapies and interventions based on an individual's genetic makeup.
The market for monogenic disease testing is experiencing steady growth due to several key market drivers. One of the primary factors driving market expansion is the increasing prevalence of genetic disorders worldwide. As awareness and understanding of genetic diseases grow, there is a rising demand for accurate and reliable testing methods to diagnose these conditions. Additionally, advancements in technology, such as next-generation sequencing and gene editing techniques, have significantly improved the efficiency and accuracy of monogenic disease testing, further fueling market growth. Moreover, the growing emphasis on personalized medicine and the shift towards preventive healthcare are driving the adoption of genetic testing services, including monogenic disease testing.
In addition to technological advancements and increasing disease prevalence, the market for monogenic disease testing is also influenced by factors such as government initiatives, healthcare infrastructure development, and strategic collaborations between industry players. Government support in the form of funding for genetic research and initiatives to integrate genetic testing into healthcare systems is boosting market growth. Furthermore, the expansion of healthcare facilities and the integration of genetic testing services into routine healthcare practices are creating more opportunities for market players. Collaborations between diagnostic laboratories, research institutions, and pharmaceutical companies are also driving innovation and expanding the range of genetic tests available in the market.
This report provides a deep insight into the global Monogenic Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Monogenic Disease Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Monogenic Disease Testing market in any manner.
Global Monogenic Disease Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Celera Support Services
Abbott
ELITech Group
Auto Genomics
PerkinElmer
Bio-Rad Laboratories
Market Segmentation (by Type)
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive and Pre-Symptomatic Testing
Prenatal Testing
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Monogenic Disease Testing Market
- Overview of the regional outlook of the Monogenic Disease Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monogenic Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Monogenic Disease Testing
1.2 Key Market Segments
1.2.1 Monogenic Disease Testing Segment by Type
1.2.2 Monogenic Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MONOGENIC DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MONOGENIC DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Monogenic Disease Testing Product Life Cycle
3.3 Global Monogenic Disease Testing Revenue Market Share by Company (2020-2025)
3.4 Monogenic Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Monogenic Disease Testing Company Headquarters, Area Served, Product Type
3.6 Monogenic Disease Testing Market Competitive Situation and Trends
3.6.1 Monogenic Disease Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monogenic Disease Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MONOGENIC DISEASE TESTING VALUE CHAIN ANALYSIS
4.1 Monogenic Disease Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MONOGENIC DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Monogenic Disease Testing Market Porter's Five Forces Analysis
6 MONOGENIC DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monogenic Disease Testing Market Size Market Share by Type (2020-2025)
6.3 Global Monogenic Disease Testing Market Size Growth Rate by Type (2021-2025)
7 MONOGENIC DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monogenic Disease Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Monogenic Disease Testing Sales Growth Rate by Application (2020-2025)
8 MONOGENIC DISEASE TESTING MARKET SEGMENTATION BY REGION
8.1 Global Monogenic Disease Testing Market Size by Region
8.1.1 Global Monogenic Disease Testing Market Size by Region
8.1.2 Global Monogenic Disease Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Monogenic Disease Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monogenic Disease Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monogenic Disease Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monogenic Disease Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monogenic Disease Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Celera Support Services
9.1.1 Celera Support Services Basic Information
9.1.2 Celera Support Services Monogenic Disease Testing Product Overview
9.1.3 Celera Support Services Monogenic Disease Testing Product Market Performance
9.1.4 Celera Support Services Monogenic Disease Testing SWOT Analysis
9.1.5 Celera Support Services Business Overview
9.1.6 Celera Support Services Recent Developments
9.2 Abbott
9.2.1 Abbott Basic Information
9.2.2 Abbott Monogenic Disease Testing Product Overview
9.2.3 Abbott Monogenic Disease Testing Product Market Performance
9.2.4 Abbott Monogenic Disease Testing SWOT Analysis
9.2.5 Abbott Business Overview
9.2.6 Abbott Recent Developments
9.3 ELITech Group
9.3.1 ELITech Group Basic Information
9.3.2 ELITech Group Monogenic Disease Testing Product Overview
9.3.3 ELITech Group Monogenic Disease Testing Product Market Performance
9.3.4 ELITech Group Monogenic Disease Testing SWOT Analysis
9.3.5 ELITech Group Business Overview
9.3.6 ELITech Group Recent Developments
9.4 Auto Genomics
9.4.1 Auto Genomics Basic Information
9.4.2 Auto Genomics Monogenic Disease Testing Product Overview
9.4.3 Auto Genomics Monogenic Disease Testing Product Market Performance
9.4.4 Auto Genomics Business Overview
9.4.5 Auto Genomics Recent Developments
9.5 PerkinElmer
9.5.1 PerkinElmer Basic Information
9.5.2 PerkinElmer Monogenic Disease Testing Product Overview
9.5.3 PerkinElmer Monogenic Disease Testing Product Market Performance
9.5.4 PerkinElmer Business Overview
9.5.5 PerkinElmer Recent Developments
9.6 Bio-Rad Laboratories
9.6.1 Bio-Rad Laboratories Basic Information
9.6.2 Bio-Rad Laboratories Monogenic Disease Testing Product Overview
9.6.3 Bio-Rad Laboratories Monogenic Disease Testing Product Market Performance
9.6.4 Bio-Rad Laboratories Business Overview
9.6.5 Bio-Rad Laboratories Recent Developments
10 MONOGENIC DISEASE TESTING MARKET FORECAST BY REGION
10.1 Global Monogenic Disease Testing Market Size Forecast
10.2 Global Monogenic Disease Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Monogenic Disease Testing Market Size Forecast by Country
10.2.3 Asia Pacific Monogenic Disease Testing Market Size Forecast by Region
10.2.4 South America Monogenic Disease Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Monogenic Disease Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Monogenic Disease Testing Market Forecast by Type (2026-2033)
11.2 Global Monogenic Disease Testing Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Monogenic Disease Testing
1.2 Key Market Segments
1.2.1 Monogenic Disease Testing Segment by Type
1.2.2 Monogenic Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MONOGENIC DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MONOGENIC DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Monogenic Disease Testing Product Life Cycle
3.3 Global Monogenic Disease Testing Revenue Market Share by Company (2020-2025)
3.4 Monogenic Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Monogenic Disease Testing Company Headquarters, Area Served, Product Type
3.6 Monogenic Disease Testing Market Competitive Situation and Trends
3.6.1 Monogenic Disease Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monogenic Disease Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MONOGENIC DISEASE TESTING VALUE CHAIN ANALYSIS
4.1 Monogenic Disease Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MONOGENIC DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Monogenic Disease Testing Market Porter's Five Forces Analysis
6 MONOGENIC DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monogenic Disease Testing Market Size Market Share by Type (2020-2025)
6.3 Global Monogenic Disease Testing Market Size Growth Rate by Type (2021-2025)
7 MONOGENIC DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monogenic Disease Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Monogenic Disease Testing Sales Growth Rate by Application (2020-2025)
8 MONOGENIC DISEASE TESTING MARKET SEGMENTATION BY REGION
8.1 Global Monogenic Disease Testing Market Size by Region
8.1.1 Global Monogenic Disease Testing Market Size by Region
8.1.2 Global Monogenic Disease Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Monogenic Disease Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monogenic Disease Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monogenic Disease Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monogenic Disease Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monogenic Disease Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Celera Support Services
9.1.1 Celera Support Services Basic Information
9.1.2 Celera Support Services Monogenic Disease Testing Product Overview
9.1.3 Celera Support Services Monogenic Disease Testing Product Market Performance
9.1.4 Celera Support Services Monogenic Disease Testing SWOT Analysis
9.1.5 Celera Support Services Business Overview
9.1.6 Celera Support Services Recent Developments
9.2 Abbott
9.2.1 Abbott Basic Information
9.2.2 Abbott Monogenic Disease Testing Product Overview
9.2.3 Abbott Monogenic Disease Testing Product Market Performance
9.2.4 Abbott Monogenic Disease Testing SWOT Analysis
9.2.5 Abbott Business Overview
9.2.6 Abbott Recent Developments
9.3 ELITech Group
9.3.1 ELITech Group Basic Information
9.3.2 ELITech Group Monogenic Disease Testing Product Overview
9.3.3 ELITech Group Monogenic Disease Testing Product Market Performance
9.3.4 ELITech Group Monogenic Disease Testing SWOT Analysis
9.3.5 ELITech Group Business Overview
9.3.6 ELITech Group Recent Developments
9.4 Auto Genomics
9.4.1 Auto Genomics Basic Information
9.4.2 Auto Genomics Monogenic Disease Testing Product Overview
9.4.3 Auto Genomics Monogenic Disease Testing Product Market Performance
9.4.4 Auto Genomics Business Overview
9.4.5 Auto Genomics Recent Developments
9.5 PerkinElmer
9.5.1 PerkinElmer Basic Information
9.5.2 PerkinElmer Monogenic Disease Testing Product Overview
9.5.3 PerkinElmer Monogenic Disease Testing Product Market Performance
9.5.4 PerkinElmer Business Overview
9.5.5 PerkinElmer Recent Developments
9.6 Bio-Rad Laboratories
9.6.1 Bio-Rad Laboratories Basic Information
9.6.2 Bio-Rad Laboratories Monogenic Disease Testing Product Overview
9.6.3 Bio-Rad Laboratories Monogenic Disease Testing Product Market Performance
9.6.4 Bio-Rad Laboratories Business Overview
9.6.5 Bio-Rad Laboratories Recent Developments
10 MONOGENIC DISEASE TESTING MARKET FORECAST BY REGION
10.1 Global Monogenic Disease Testing Market Size Forecast
10.2 Global Monogenic Disease Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Monogenic Disease Testing Market Size Forecast by Country
10.2.3 Asia Pacific Monogenic Disease Testing Market Size Forecast by Region
10.2.4 South America Monogenic Disease Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Monogenic Disease Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Monogenic Disease Testing Market Forecast by Type (2026-2033)
11.2 Global Monogenic Disease Testing Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monogenic Disease Testing Market Size Comparison by Region (M USD)
Table 5. Global Monogenic Disease Testing Revenue (M USD) by Company (2020-2025)
Table 6. Global Monogenic Disease Testing Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenic Disease Testing as of 2024)
Table 8. Monogenic Disease Testing Company Headquarters and Area Served
Table 9. Company Monogenic Disease Testing Product Type
Table 10. Global Monogenic Disease Testing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Monogenic Disease Testing Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Monogenic Disease Testing Market Size by Type (M USD)
Table 21. Global Monogenic Disease Testing Market Size (M USD) by Type (2020-2025)
Table 22. Global Monogenic Disease Testing Market Size Share by Type (2020-2025)
Table 23. Global Monogenic Disease Testing Market Size Growth Rate by Type (2021-2025)
Table 24. Global Monogenic Disease Testing Market Size by Application
Table 25. Global Monogenic Disease Testing Market Size by Application (2020-2025) & (M USD)
Table 26. Global Monogenic Disease Testing Market Share by Application (2020-2025)
Table 27. Global Monogenic Disease Testing Sales Growth Rate by Application (2020-2025)
Table 28. Global Monogenic Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 29. Global Monogenic Disease Testing Market Size Market Share by Region (2020-2025)
Table 30. North America Monogenic Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Monogenic Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Monogenic Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 33. South America Monogenic Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Monogenic Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 35. Celera Support Services Basic Information
Table 36. Celera Support Services Monogenic Disease Testing Product Overview
Table 37. Celera Support Services Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Celera Support Services Monogenic Disease Testing SWOT Analysis
Table 39. Celera Support Services Business Overview
Table 40. Celera Support Services Recent Developments
Table 41. Abbott Basic Information
Table 42. Abbott Monogenic Disease Testing Product Overview
Table 43. Abbott Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Abbott Monogenic Disease Testing SWOT Analysis
Table 45. Abbott Business Overview
Table 46. Abbott Recent Developments
Table 47. ELITech Group Basic Information
Table 48. ELITech Group Monogenic Disease Testing Product Overview
Table 49. ELITech Group Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 50. ELITech Group Monogenic Disease Testing SWOT Analysis
Table 51. ELITech Group Business Overview
Table 52. ELITech Group Recent Developments
Table 53. Auto Genomics Basic Information
Table 54. Auto Genomics Monogenic Disease Testing Product Overview
Table 55. Auto Genomics Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 56. Auto Genomics Business Overview
Table 57. Auto Genomics Recent Developments
Table 58. PerkinElmer Basic Information
Table 59. PerkinElmer Monogenic Disease Testing Product Overview
Table 60. PerkinElmer Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 61. PerkinElmer Business Overview
Table 62. PerkinElmer Recent Developments
Table 63. Bio-Rad Laboratories Basic Information
Table 64. Bio-Rad Laboratories Monogenic Disease Testing Product Overview
Table 65. Bio-Rad Laboratories Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Bio-Rad Laboratories Business Overview
Table 67. Bio-Rad Laboratories Recent Developments
Table 68. Global Monogenic Disease Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 69. North America Monogenic Disease Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 70. Europe Monogenic Disease Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 71. Asia Pacific Monogenic Disease Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 72. South America Monogenic Disease Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 73. Middle East and Africa Monogenic Disease Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 74. Global Monogenic Disease Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 75. Global Monogenic Disease Testing Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monogenic Disease Testing Market Size Comparison by Region (M USD)
Table 5. Global Monogenic Disease Testing Revenue (M USD) by Company (2020-2025)
Table 6. Global Monogenic Disease Testing Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenic Disease Testing as of 2024)
Table 8. Monogenic Disease Testing Company Headquarters and Area Served
Table 9. Company Monogenic Disease Testing Product Type
Table 10. Global Monogenic Disease Testing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Monogenic Disease Testing Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Monogenic Disease Testing Market Size by Type (M USD)
Table 21. Global Monogenic Disease Testing Market Size (M USD) by Type (2020-2025)
Table 22. Global Monogenic Disease Testing Market Size Share by Type (2020-2025)
Table 23. Global Monogenic Disease Testing Market Size Growth Rate by Type (2021-2025)
Table 24. Global Monogenic Disease Testing Market Size by Application
Table 25. Global Monogenic Disease Testing Market Size by Application (2020-2025) & (M USD)
Table 26. Global Monogenic Disease Testing Market Share by Application (2020-2025)
Table 27. Global Monogenic Disease Testing Sales Growth Rate by Application (2020-2025)
Table 28. Global Monogenic Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 29. Global Monogenic Disease Testing Market Size Market Share by Region (2020-2025)
Table 30. North America Monogenic Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Monogenic Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Monogenic Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 33. South America Monogenic Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Monogenic Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 35. Celera Support Services Basic Information
Table 36. Celera Support Services Monogenic Disease Testing Product Overview
Table 37. Celera Support Services Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Celera Support Services Monogenic Disease Testing SWOT Analysis
Table 39. Celera Support Services Business Overview
Table 40. Celera Support Services Recent Developments
Table 41. Abbott Basic Information
Table 42. Abbott Monogenic Disease Testing Product Overview
Table 43. Abbott Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Abbott Monogenic Disease Testing SWOT Analysis
Table 45. Abbott Business Overview
Table 46. Abbott Recent Developments
Table 47. ELITech Group Basic Information
Table 48. ELITech Group Monogenic Disease Testing Product Overview
Table 49. ELITech Group Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 50. ELITech Group Monogenic Disease Testing SWOT Analysis
Table 51. ELITech Group Business Overview
Table 52. ELITech Group Recent Developments
Table 53. Auto Genomics Basic Information
Table 54. Auto Genomics Monogenic Disease Testing Product Overview
Table 55. Auto Genomics Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 56. Auto Genomics Business Overview
Table 57. Auto Genomics Recent Developments
Table 58. PerkinElmer Basic Information
Table 59. PerkinElmer Monogenic Disease Testing Product Overview
Table 60. PerkinElmer Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 61. PerkinElmer Business Overview
Table 62. PerkinElmer Recent Developments
Table 63. Bio-Rad Laboratories Basic Information
Table 64. Bio-Rad Laboratories Monogenic Disease Testing Product Overview
Table 65. Bio-Rad Laboratories Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Bio-Rad Laboratories Business Overview
Table 67. Bio-Rad Laboratories Recent Developments
Table 68. Global Monogenic Disease Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 69. North America Monogenic Disease Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 70. Europe Monogenic Disease Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 71. Asia Pacific Monogenic Disease Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 72. South America Monogenic Disease Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 73. Middle East and Africa Monogenic Disease Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 74. Global Monogenic Disease Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 75. Global Monogenic Disease Testing Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Monogenic Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monogenic Disease Testing Market Size (M USD), 2024-2033
Figure 5. Global Monogenic Disease Testing Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Monogenic Disease Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Monogenic Disease Testing Product Life Cycle
Figure 12. Global Monogenic Disease Testing Revenue Share by Company in 2024
Figure 13. Monogenic Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Monogenic Disease Testing Revenue in 2024
Figure 15. Value Chain Map of Monogenic Disease Testing
Figure 16. Global Monogenic Disease Testing Market PESTE Analysis
Figure 17. Global Monogenic Disease Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Monogenic Disease Testing Market Share by Type
Figure 20. Market Size Share of Monogenic Disease Testing by Type (2020-2025)
Figure 21. Market Size Share of Monogenic Disease Testing by Type in 2024
Figure 22. Global Monogenic Disease Testing Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Monogenic Disease Testing Market Share by Application
Figure 25. Global Monogenic Disease Testing Market Share by Application (2020-2025)
Figure 26. Global Monogenic Disease Testing Market Share by Application in 2024
Figure 27. Global Monogenic Disease Testing Sales Growth Rate by Application (2020-2025)
Figure 28. Global Monogenic Disease Testing Market Size Market Share by Region (2020-2025)
Figure 29. North America Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Monogenic Disease Testing Market Size Market Share by Country in 2024
Figure 31. U.S. Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Monogenic Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Monogenic Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Monogenic Disease Testing Market Share by Country in 2024
Figure 36. Germany Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Russia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Monogenic Disease Testing Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Monogenic Disease Testing Market Size Market Share by Region in 2024
Figure 43. China Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Monogenic Disease Testing Market Size and Growth Rate (M USD)
Figure 49. South America Monogenic Disease Testing Market Size Market Share by Country in 2024
Figure 50. Brazil Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Monogenic Disease Testing Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Monogenic Disease Testing Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Monogenic Disease Testing Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Monogenic Disease Testing Market Share Forecast by Type (2026-2033)
Figure 62. Global Monogenic Disease Testing Market Share Forecast by Application (2026-2033)
Figure 1. Industry Chain of Monogenic Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monogenic Disease Testing Market Size (M USD), 2024-2033
Figure 5. Global Monogenic Disease Testing Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Monogenic Disease Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Monogenic Disease Testing Product Life Cycle
Figure 12. Global Monogenic Disease Testing Revenue Share by Company in 2024
Figure 13. Monogenic Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Monogenic Disease Testing Revenue in 2024
Figure 15. Value Chain Map of Monogenic Disease Testing
Figure 16. Global Monogenic Disease Testing Market PESTE Analysis
Figure 17. Global Monogenic Disease Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Monogenic Disease Testing Market Share by Type
Figure 20. Market Size Share of Monogenic Disease Testing by Type (2020-2025)
Figure 21. Market Size Share of Monogenic Disease Testing by Type in 2024
Figure 22. Global Monogenic Disease Testing Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Monogenic Disease Testing Market Share by Application
Figure 25. Global Monogenic Disease Testing Market Share by Application (2020-2025)
Figure 26. Global Monogenic Disease Testing Market Share by Application in 2024
Figure 27. Global Monogenic Disease Testing Sales Growth Rate by Application (2020-2025)
Figure 28. Global Monogenic Disease Testing Market Size Market Share by Region (2020-2025)
Figure 29. North America Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Monogenic Disease Testing Market Size Market Share by Country in 2024
Figure 31. U.S. Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Monogenic Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Monogenic Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Monogenic Disease Testing Market Share by Country in 2024
Figure 36. Germany Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Russia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Monogenic Disease Testing Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Monogenic Disease Testing Market Size Market Share by Region in 2024
Figure 43. China Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Monogenic Disease Testing Market Size and Growth Rate (M USD)
Figure 49. South America Monogenic Disease Testing Market Size Market Share by Country in 2024
Figure 50. Brazil Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Monogenic Disease Testing Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Monogenic Disease Testing Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Monogenic Disease Testing Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Monogenic Disease Testing Market Share Forecast by Type (2026-2033)
Figure 62. Global Monogenic Disease Testing Market Share Forecast by Application (2026-2033)
